SecBot SecBot
3 ·Filed Jul 6, 2026

TAK

TAKEDA PHARMACEUTICAL CO LTD
NEUTRAL
Impact 2/10
Horizonimmediate Processed4mo ago SEC0001395064-26-000240
Form 3, initial insider ownership statement
Actionable Insight • Neutral

This is a routine initial ownership filing by a new insider. No trading signal. Monitor for future Form 4 filings to track any subsequent open-market purchases or sales by this insider.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$16.89
T+0 close · Jul 6, 2026 · via day close
Latest settled
+9.59%
T+60 · $18.51
Vs SPY
+7.68%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jul 6 $16.89entry
  2. T+1 · 4mo ago +0.41%α +0.89% · $16.96
  3. T+5 · 4mo ago −1.95%α −2.44% · $16.56
  4. T+20 · 4mo ago +1.18%α +1.75% · $17.09
  5. T+60 · 7w ago +9.59%α +7.68% · $18.51
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Bruce Broussard filed a Form 3 initial statement of beneficial ownership with the SEC, reporting 795 American Depositary Shares in Takeda Pharmaceutical Co Ltd. The filing also includes a power of attorney authorizing legal counsel to execute future Section 16 filings. This is a routine administrative filing by a new insider and has no material impact on the company's operations or financials.

Key Facts

  • Bruce Broussard filed a Form 3 initial statement of beneficial ownership
  • Reports beneficial ownership of 795 American Depositary Shares in Takeda Pharmaceutical Co Ltd
  • Filing includes a power of attorney for Section 16 and Rule 144 filings
  • No material financial data, guidance, or operational changes disclosed

Financial Impact

No material financial impact; 795 ADS stake is negligible relative to Takeda's $2.4B market cap

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations
Analyst Consensus
68% bullish (19 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
3 Filing (Primary)0001395064-26-000240
Document: 0001395064-26-000240-index-headers.html0001395064-26-000240
Document: 0001395064-26-000240-index.html0001395064-26-000240
Document: 0001395064-26-000240.txt0001395064-26-000240

Track record

18 reports on TAK

Performance horizon

The track record builds as more bullish or bearish reports settle.

Filters
  1. Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $21.19 to $21.12 Now $21.59 +1.89% ▼ −0.33% −3.62% vs SPY
  2. Oct 30, 202617d ago 144 Neutral 2/10 Entry $20.87 to $21.09 Now $21.59 +3.45% ▲ +1.05% +0.98% vs SPY
  3. Oct 30, 202617d ago 144 Neutral 2/10 Entry $20.87 to $21.09 Now $21.59 +3.45% ▲ +1.05% +0.98% vs SPY
  4. Oct 29, 202618d ago 6-K Neutral 4/10 No price data
  5. Oct 29, 202618d ago 6-K Bearish 5/10 Entry $20.01 to $21.19 Now $21.59 −7.90% ▼ −5.90% −10.62% vs SPY
  6. Sep 14, 20269w ago 6-K Bullish 7/10 Entry $18.60 to $18.89 Now $21.59 +16.08% ▲ +1.56% +1.45% vs SPY
  7. Aug 21, 202612w ago Insider Cluster Neutral 2/10 Entry $18.24 to $17.98 Now $21.59 +18.37% ▼ −1.43% −1.89% vs SPY
  8. Aug 19, 202612w ago Insider Cluster Neutral 2/10 Entry $18.13 to $18.03 Now $21.59 +19.08% ▼ −0.55% −1.67% vs SPY
  9. Aug 14, 202613w ago Court Ruling Neutral 4/10 Entry $17.38 to $18.24 Now $21.59 +24.22% ▲ +4.95% +6.14% vs SPY
  10. Aug 12, 202613w ago Insider Cluster Neutral 3/10 Entry $17.39 to $18.13 Now $21.59 +24.15% ▲ +4.26% +6.22% vs SPY
Showing 10 of 18

US Market Status

Market Closed · Opens Wed (9h 49m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 6, 2026